Deals19 Oct 2026, 06:00 pm
Dhampur Bio Organics Signs Tech License for Mycoprotein Production
AI Summary
Dhampur Bio Organics Limited (DBO) has entered into a Technology Licensing Agreement with Planetary SA, Switzerland, for the exclusive production of Mycoprotein in India. The agreement, effective October 19, 2026, outlines a collaboration model where Planetary provides technology and acts as an off-taker, while DBO will construct and operate the production infrastructure. DBO will pay Planetary a licensing fee of 10% of after-tax revenue quarterly, plus a one-time launch fee for engineering and support. The agreement has an initial term of 10 years, renewable for successive 5-year terms. This partnership aims to establish Mycoprotein commercialization and offtake in India.
Key Highlights
- Dhampur Bio Organics licenses Mycoprotein production technology from Planetary SA.
- DBO to construct and operate production infrastructure in India.
- Planetary SA to provide technology and act as off-taker.
- Royalty fee set at 10% of after-tax revenue quarterly.
- Initial agreement term of 10 years, with renewal options.
Price Impact
More from DBOL